TUMORMARKERSㅣTHYROIDㅣFERTILITYㅣENDOCRINOLOGYㅣDIABETESㅣANEMIAㅣPHOSPHOCALCIC AXISㅣCARDIAC MARKERSㅣHEPATITISㅣOTHERS
 

PRODUCT

REF.
(No of tubes)

METHOD
SEPARATION

TRACER
ACT (kBq)

STANDARD
(No and Range)

CONTROLS

SAMPLE
(Vol. and type)

INCUBATIONS
(Time/T°)

SHELF-LIFE
(Labelling
periodicity)

COMMENTS

OSTEO
CALCIN

ELSA-OSTEO
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
555

5
0 → 300pg/ml

1

50μl
Serum, plasma

2 h
RT

6 weeks
(every 4 weeks)

Anti-human osteocalcin monoclonal antibodies Human osteocalcin Stds Only heparin plasma

ELSA-OST-NAT
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
555

5
0 → 180pg/ml

1

50μl
Plasma

2 h
RT

6 weeks
(every 4 weeks)

 Anti-human osteocalcin monoclonal antibodies Human osteocalcin Stds Only intact molecule detection

PTH 1-84

ELSA-PTH
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
555

6
0 → 1500ng/ml

1

200μl
Serum, plasma

18 h / RT
or
quick procedure

4 weeks
(every 3 weeks)

Oligoclonal/polyclonal antibodies Intact PTH only intraoperative "quick" procedure